Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax

Total 11 results found. Search for [ Zhuhai Livzon Diagnostics ]

Results 1 to 11 of 11
May 14, 2020
According to the guidance issued on Wednesday, the ICMR stated these tests can be done on blood/serum/plasma samples, the results of which are available within 30 minutes and the test comes positive after 7-10 days of infection

New Delhi, May 1, 2020
Three days back, China had fumed, saying it was \"deeply concerned\" with the evaluation results and ICMR's decision to stop the use of these anti-body kits

New Delhi, April 29, 2020
ICMR, India's nodal body monitoring Covid-19 in India, has asked the state governments to return the rapid antibody test kits from China. It said that the rapid antibody tests showed a wide variation in results, which was against the assurances given by the manufacturers. However, China has expressed concern and questioned the handling of the testing kits by Indian agencies. It defended the two Chinese companies, Guangzhou Wondfo Biotech and Zhuhai Livzon Diagnostics, stating that their COVID-19 antibody rapid test kits had obtained the certification from the National Medical Products Administration of China (NMPA) and were validated and approved by ICMR through National Institute of Virology (NIV), Pune. Watch the video for more.Also Read: Hester Biosciences stock surges 20% on collaboration with IIT Guwahati for COVID-19 vaccine

Joe C Mathew
April 28, 2020
While the legality of the issue will get sorted out in the coming days, one thing is certain that the scramble for a share in the thriving business of rapid diagnostic kit supplies for COVID-19 is leaving several grey areas for potential legal tussles

New Delhi, April 28, 2020
Indian side could respect China's goodwill and sincerity, strengthen communication timely with relevant Chinese companies based on facts, and resolve it reasonably and properly, says the embassy

Ashish Pandey | Mudit Kapoor
New Delhi, April 27, 2020
Kripa Shanker Gupta's  LinkedIn account says he is a passionate 'medi-preneur' with a deep understanding of Indian health landscape and ability to innovate new health programmes in public and private health

New Delhi, April 27, 2020
ICMR says it decided to go with Wondfo as its exclusive distributor for kits, as it quoted an all-inclusive price, without any clause for advance; apex medical research body has told states to stop using rapid anti-body test kits over \"wide variation\"

New Delhi, April 27, 2020
ICMR says it evaluated testing kits of Guangzhou Wondfo Biotech and Zhuhai Livzon Diagnostics in field conditions and results showed \"wide variation\" despite promise of \"good performance for surveillance purposes\"

Geeta Mohan
April 24, 2020
Coronavirus update: The batch India received was from two Chinese companies, Guangzhou Wondfo Biotech that provided 3 lakh kits and Zhuhai Livzon Diagnostics that provided 2.5 lakh kits

PB Jayakumar
New Delhi, April 13, 2020
Sources said the ICMR's initial orders for 5 lakh kits included the Chinese firm Wondfo, which has the NMPA clearance. Nevertheless the firm did not honour its commitment

E Kumar Sharma
New Delhi, April 12, 2020
Rapid tests are expected to start soon. What is holding back testing at the moment is that all kits are imported, mostly from China, and supplies are not enough